Molecular characteristics of KPC-producing Klebsiella pneumoniae isolates from children and adults in Kunming
4 affiliations
- 1Kunming Children’s Hospital (Kunming Medical University Affiliated), Kunming, China
- 2The First People’s Hospital of Kunming, Kunming, China
- 3The First People’s Hospital of Yunnan Province, Kunming, China
- 4Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China
Abstract
The increasing prevalence of KPC-producing Klebsiella pneumoniae (KPC-Kp) poses a critical public health threat. While Sequence Type 11 (ST11) is the dominant carbapenem-resistant clone in China, the comparative molecular characteristics of isolates affecting distinct patient demographics remain understudied. Fifty non-duplicate KPC-Kp clinical isolates (18 from children, 32 from adults) were prospectively collected from four hospitals in Kunming during 2023. Whole-genome sequencing was performed to determine multilocus sequence types (MLST), capsular serotypes (KL types), plasmid replicons, and resistance/virulence gene profiles. Phylogenetic relationships were reconstructed using single-nucleotide polymorphisms and core-genome MLST. All isolates carried blaKPC-2, and 98% (49/50) belonged to ST11. Pediatric isolates were predominantly ST11-KL47 (72.2%), exhibiting a classic multidrug-resistant profile, whereas adult isolates were dominated by ST11-KL64 (59.4%) and frequently harbored IncFIB/IncH1IB virulence plasmids carrying rmpA, iuc, and iro genes, indicating a hypervirulent phenotype (CR-hvKP). Kunming isolates were genetically closely related to strains from other Chinese provinces, suggesting that local CRKP epidemiology is shaped by national dissemination of successful ST11 clones rather than isolated regional outbreaks. Although ST11 drives the regional KPC-Kp epidemic, the molecular characteristics of isolates from children and adults are distinct. The shared ST11 genetic backbone and the presence of transferable virulence plasmids in adult isolates raise a potential risk of cross-population spread. Continuous genomic surveillance is essential to monitor the possible horizontal transfer of virulence plasmids from adult to pediatric reservoirs.
IMPORTANCE: This study investigated 50 KPC-2-producing Klebsiella pneumoniae isolates from four hospitals in Kunming (2023). Nearly all (98%) belonged to ST11, confirming this clone drives the regional carbapenem-resistant epidemic. However, striking differences emerged between pediatric and adult isolates. Pediatric isolates were predominantly ST11-KL47 (72.2%) with a classic multidrug-resistant profile, whereas adult isolates were mainly ST11-KL64 (59.4%) and frequently carried IncFIB/IncH1IB virulence plasmids harboring rmpA, iuc, and iro genes, indicating a hypervirulent phenotype (CR-hvKP). Phylogenetic analysis revealed that Kunming strains are closely related to those from other Chinese provinces, suggesting national dissemination of successful ST11 clones rather than isolated local outbreaks. Although adult virulence plasmids were not found in pediatric isolates, the shared ST11 genetic backbone raises concerns about potential horizontal transfer of these plasmids from adult to pediatric populations. Continuous genomic surveillance is essential to monitor this cross‑population risk.
Related
- Phenotypic and molecular characterization of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae isolates from communities in South Western Uganda
- Genomic analysis and antimicrobial resistance profiling of Klebsiella pneumoniae clinical isolates from urinary tract infections in India: prevalence of class A β-lactamase with molecular docking and simulation insights.
- Genomics of multidrug-resistant Klebsiella pneumoniae isolates from community hospitals in Pretoria, South Africa
- Clinical characteristics, molecular features and in vitro susceptibility to sulbactam-durlobactam, cefiderocol, and eravacycline in NDM-1-producing versus OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates from children in Guangxi, China.
- Rapid inter-regional and cross-border dissemination of carbapenemase-producing Klebsiella pneumoniae ST6668, European Union, April 2022 to August 2026.
BibTeX
@article{wang2026molecular,
title = {{Molecular characteristics of KPC-producing Klebsiella pneumoniae isolates from children and adults in Kunming}},
author = {Wenting Wang and Jing Qian and Rui Zheng and Hanyu Liu and Xiaoli Jian and Jinglin Zhao and Yuanqing Liang and Lanhua Bao and Min Su and Yuan Chen and Yaofang Hang and Jianguo Wu and Xiao You and Adong Shen and Dingrui Han and Li Jiang and Xiaomei Liu},
journal = {Microbiology Spectrum},
year = {2026},
month = sep,
doi = {10.1128/spectrum.01813-26},
url = {https://doi.org/10.1128/spectrum.01813-26},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Molecular characteristics of KPC-producing Klebsiella pneumoniae isolates from children and adults in Kunming
AU - Wenting Wang
AU - Jing Qian
AU - Rui Zheng
AU - Hanyu Liu
AU - Xiaoli Jian
AU - Jinglin Zhao
AU - Yuanqing Liang
AU - Lanhua Bao
AU - Min Su
AU - Yuan Chen
AU - Yaofang Hang
AU - Jianguo Wu
AU - Xiao You
AU - Adong Shen
AU - Dingrui Han
AU - Li Jiang
AU - Xiaomei Liu
PY - 2026
DA - 2026/09/23
JO - Microbiology Spectrum
DO - 10.1128/spectrum.01813-26
UR - https://doi.org/10.1128/spectrum.01813-26
AB - The increasing prevalence of KPC-producing Klebsiella pneumoniae (KPC-Kp) poses a critical public health threat. While Sequence Type 11 (ST11) is the dominant carbapenem-resistant clone in China, the comparative molecular characteristics of isolates affecting distinct patient demographics remain understudied. Fifty non-duplicate KPC-Kp clinical isolates (18 from children, 32 from adults) were prospectively collected from four hospitals in Kunming during 2023. Whole-genome sequencing was performed to determine multilocus sequence types (MLST), capsular serotypes (KL types), plasmid replicons, and resistance/virulence gene profiles. Phylogenetic relationships were reconstructed using single-nucleotide polymorphisms and core-genome MLST. All isolates carried blaKPC-2, and 98% (49/50) belonged to ST11. Pediatric isolates were predominantly ST11-KL47 (72.2%), exhibiting a classic multidrug-resistant profile, whereas adult isolates were dominated by ST11-KL64 (59.4%) and frequently harbored IncFIB/IncH1IB virulence plasmids carrying rmpA, iuc, and iro genes, indicating a hypervirulent phenotype (CR-hvKP). Kunming isolates were genetically closely related to strains from other Chinese provinces, suggesting that local CRKP epidemiology is shaped by national dissemination of successful ST11 clones rather than isolated regional outbreaks. Although ST11 drives the regional KPC-Kp epidemic, the molecular characteristics of isolates from children and adults are distinct. The shared ST11 genetic backbone and the presence of transferable virulence plasmids in adult isolates raise a potential risk of cross-population spread. Continuous genomic surveillance is essential to monitor the possible horizontal transfer of virulence plasmids from adult to pediatric reservoirs. IMPORTANCE: This study investigated 50 KPC-2-producing Klebsiella pneumoniae isolates from four hospitals in Kunming (2023). Nearly all (98%) belonged to ST11, confirming this clone drives the regional carbapenem-resistant epidemic. However, striking differences emerged between pediatric and adult isolates. Pediatric isolates were predominantly ST11-KL47 (72.2%) with a classic multidrug-resistant profile, whereas adult isolates were mainly ST11-KL64 (59.4%) and frequently carried IncFIB/IncH1IB virulence plasmids harboring rmpA, iuc, and iro genes, indicating a hypervirulent phenotype (CR-hvKP). Phylogenetic analysis revealed that Kunming strains are closely related to those from other Chinese provinces, suggesting national dissemination of successful ST11 clones rather than isolated local outbreaks. Although adult virulence plasmids were not found in pediatric isolates, the shared ST11 genetic backbone raises concerns about potential horizontal transfer of these plasmids from adult to pediatric populations. Continuous genomic surveillance is essential to monitor this cross‑population risk.
SN - 2165-0497
ER -